Breast cancer tumor growth estimated through mammography screening data

[1]  Odd O Aalen,et al.  Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results , 2005, Journal of medical screening.

[2]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.

[3]  Anne M Kavanagh,et al.  Hormone replacement therapy and accuracy of mammographic screening , 2000, The Lancet.

[4]  H. M. Taylor,et al.  An introduction to stochastic modeling , 1985 .

[5]  J S Spratt,et al.  Rates of growth of human neoplasms: Part II , 1996, Journal of surgical oncology.

[6]  L. Tabár,et al.  Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. , 1995, Statistics in medicine.

[7]  S. Duffy,et al.  Quantitative methods for the evaluation of cancer screening , 2009 .

[8]  J D Habbema,et al.  The MISCAN simulation program for the evaluation of screening for disease. , 1985, Computer methods and programs in biomedicine.

[9]  Mark Garton,et al.  Breast cancer and hormone-replacement therapy: the Million Women Study , 2003, The Lancet.

[10]  R. Bartoszynski,et al.  Estimation of human tumor growth rate from distribution of tumor size at detection. , 1984, Journal of the National Cancer Institute.

[11]  A. Eggen,et al.  Hormone replacement therapy and incidence of hormone‐dependent cancers in the Norwegian Women and Cancer study , 2004, International journal of cancer.

[12]  B. Møller,et al.  The influence of mammographic screening on national trends in breast cancer incidence , 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[13]  J D Habbema,et al.  A model for breast cancer screening , 1990, Cancer.

[14]  N. Day,et al.  Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. , 1984, Biometrics.

[15]  J. Meyer,et al.  Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[16]  Michael R. Chernick,et al.  Bootstrap Methods: A Practitioner's Guide , 1999 .

[17]  Brett Presnell,et al.  Bootstrap Methods: A Practitioner's Guide , 2002 .

[18]  J. Litherland,et al.  The effect of hormone replacement therapy on the sensitivity of screening mammograms. , 1999, Clinical radiology.

[19]  P. Skrabanek.  The Cost-effectiveness of Breast Cancer Screening , 1991, International Journal of Technology Assessment in Health Care.

[20]  S. Duffy,et al.  Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986). , 1991, International journal of epidemiology.

[21]  L. Norton.  A Gompertzian model of human breast cancer growth. , 1988, Cancer research.

[22]  J. Spratt,et al.  Mammographic assessment of human breast cancer growth and duration. , 1993, Cancer.

[23]  Roland Holland,et al.  Age‐dependent growth rate of primary breast cancer , 1993, Cancer.

[24]  Angela Mariotto,et al.  Cancer Intervention and Surveillance Modeling Network (CISNET) , 2001, Journal of Investigative Medicine.

[25]  V. Beral.  Ovarian cancer and hormone replacement therapy in the Million Women Study , 2007, The Lancet.

[26]  J. Habbema,et al.  The cost‐effectiveness of breast cancer screening , 1989, International journal of cancer.

[27]  G. Hortobagyi,et al.  Spontaneous regression of breast carcinoma: Follow‐up report and literature review , 1982, Journal of surgical oncology.

[28]  P. Skaane,et al.  Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program , 2007, European Journal of Epidemiology.

[29]  L. Tabár,et al.  Efficacy of breast cancer screening by age. New results swedish two‐county trial , 1995, Cancer.

[30]  S K Plevritis,et al.  A mathematical algorithm that computes breast cancer sizes and doubling times detected by screening. , 2001, Mathematical biosciences.

[31]  F. Hartveit,et al.  Size of breast carcinomas at operation related to tumour growth rate , 1987, Breast Cancer Research and Treatment.

[32]  D. Zaridze,et al.  Incidence of cancer of the lung stomach, breast, and cervix in the USSR: pattern and trends , 1990, Cancer Causes & Control.

[33]  P. Porter,et al.  Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. , 1999, Journal of the National Cancer Institute.

[34]  S. Duffy,et al.  Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches. , 1998, American journal of epidemiology.

[35]  J S Spratt,et al.  Decelerating growth and human breast cancer , 1993, Cancer.

[36]  Arild Hervik,et al.  Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modeled nationwide screening , 2004, Cancer Causes & Control.

[37]  J S Spratt,et al.  Rates of growth of human solid neoplasms: Part I , 1995, Journal of surgical oncology.

[38]  N. Boyd,et al.  Case-control study of factors associated with failure to detect breast cancer by mammography. , 1992, Journal of the National Cancer Institute.

[39]  Z. Agur,et al.  The growth law of primary breast cancer as inferred from mammography screening trials data. , 1998, British Journal of Cancer.